An expert opinion would be great, my simple mind says the DMC continuation could mean:
Worst case same as control group maybe slight improvement
Best case results that mirror phase 2
I don’t believe there are many options for these patients, which is why the DMC would not stop it even if the results are negligible and why it is such a potential gold mine.
The better argument is the MACE events ended at the expected date, which might mean the results mirror the expectation or the control group outperformed expectations
I think heart might fail but the CBLP will be a winner.
Remember when everyone said the LVAD was a sure success?
An expert opinion would be great, my simple mind says the DMC...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.63 |
Change
0.015(0.93%) |
Mkt cap ! $2.089B | |||
| Open | High | Low | Value | Volume |
| $1.63 | $1.67 | $1.61 | $4.486M | 2.737M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 7 | 4304 | $1.63 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.64 | 12141 | 28 |
View Market Depth
| Last trade - 13.08pm 04/07/2025 (20 minute delay) ? |
| MSB (ASX) Chart |